Jennifer Alton | President
Pathway Policy Group

Jennifer Alton, President, Pathway Policy Group

Jenn Alton is President of Pathway Policy Group, a public policy, strategic advisory and advocacy consulting firm.  She is a recognized leader in policy design and public health advocacy, bringing more than two decades of experience across senior corporate and federal government roles. Jenn advises senior leaders in the private, non-profit and public sectors on external affairs strategies and organizational structure, including government relations, coalition building, and strategic communications. She also serves as a member of the CSIS Bipartisan Alliance for Global Health Security. Jenn previously served on Capitol Hill as Public Health Policy Director on the U.S. Senate Health, Education, Labor, and Pensions Committee for Senator Richard Burr. She led the development and negotiation of major public health legislation, including the bipartisan Pandemic and All-Hazards Preparedness Act, which strengthened the nation’s health security posture and created two cornerstone offices at the Department of Health and Human Services (HHS): the Biomedical Advanced Research and Development Authority (BARDA) and the Assistant Secretary for Preparedness and Response (ASPR).

In the biotechnology sector, Jenn led the establishment of the U.S. government affairs office for a multinational company developing vaccines for infectious diseases and cancer immunotherapies. As Vice President of Public Policy and Government Affairs, she oversaw federal policy strategy, political advocacy, public affairs, alliance development, and trade association engagement for eight years.

Her federal government experience also includes serving at HHS as a senior advisor to the former Assistant Secretary for Preparedness and Response. As a Presidential Management Fellow at HHS, she focused on budget formulation and legislative affairs, earning the Secretary’s Award for Distinguished Service. Jenn earned her Master of Public Policy degree from the UCLA Luskin School of Public Affairs.  
 

Appearances:



Main Conference Day 1 - 9th March @ 17:30

Panel - Governing Dual-Use AI: Translating Risk Models into Actionable Policy, Industry Standards, and Global Compliance

  • Balancing Innovation & Safeguards: Evaluating how policy can mitigate dual-use AI misuse without inadvertently blocking legitimate scientific discovery, while exploring mechanisms like "Know-Your-Customer" protocols to protect open research.    
  • Self-Regulation vs. Federal Mandates: Examining the trade-offs, penalties, and commercial advantages of industry self-regulation versus statutory regulation and evaluating whether government-enforceable standards provide needed clarity for frontier developers.    
  • Bridging Jurisdiction-Specific Policy Frameworks: Comparing hands-off vs. centralized regulatory approaches across the US, EU, and Asian markets, and identifying flexible policy mechanisms that align international biosecurity goals despite differing domestic laws.    
  • Global Equity & Compliance Infrastructure: Developing policy mechanisms and third-party oversight models that allow low- and middle-income countries to benefit from frontier AI biological tools without introducing biosecurity vulnerabilities.
last published: 16/Nov/26 13:20 GMT

back to speakers